Drug Type Small molecule drug |
Synonyms Bimatoprost and Timolol Maleate, Bimatoprost/Timolol, Ganfort + [6] |
Action agonists, antagonists |
Mechanism Prostanoid receptor agonists, β-adrenoceptors antagonists(Beta adrenergic receptors antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date European Union (19 May 2006), |
Regulation- |
Molecular FormulaC17H28N4O7S |
InChIKeyWLRMANUAADYWEA-NWASOUNVSA-N |
CAS Registry26921-17-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Glaucoma, Open-Angle | Norway | 19 May 2006 | |
Glaucoma, Open-Angle | Iceland | 19 May 2006 | |
Glaucoma, Open-Angle | European Union | 19 May 2006 | |
Glaucoma, Open-Angle | Liechtenstein | 19 May 2006 | |
Ocular Hypertension | European Union | 19 May 2006 | |
Ocular Hypertension | Norway | 19 May 2006 | |
Ocular Hypertension | Iceland | 19 May 2006 | |
Ocular Hypertension | Liechtenstein | 19 May 2006 |
Phase 4 | 81 | (Bimatoprost 0.03%/Timolol 0.5% Combination Ophthalmic Solution) | pksqbfnspt(ujyvbawhyj) = oxfxxyhdwg sfjqjzbupx (jkfsfdpfid, mvglvsmzlw - ynhljmxqnd) View more | - | 26 Feb 2013 | ||
(Latanoprost 0.005% Ophthalmic Solution) | pksqbfnspt(ujyvbawhyj) = stipsnquwq sfjqjzbupx (jkfsfdpfid, wtxrpdlqsg - fpqzfznavz) View more | ||||||
Not Applicable | 235 | (0.03% Bimatoprost/0.5% Timolol in Same Bottle) | yyilnbunum(xtuyvbltbb) = njnvtczpcc gqlzyldfma (yyaizgputn, llqqatgrjq - qpyqeoctwk) View more | - | 20 Jan 2012 | ||
(0.03% Bimatoprost and 0.5% Timolol in Separate Bottles) | yyilnbunum(xtuyvbltbb) = edogdngbkq gqlzyldfma (yyaizgputn, fxfhgniscc - wnpygayrti) View more | ||||||
Phase 3 | 1,061 | (ogfxwnleok) = GAN, a single-bottle, fixed combination represents a convenient, therapeutic advantage over separate bottles yrelzghtbq (lnifhpaqbg ) | Positive | 01 May 2007 | |||
Bimatoprost |